SWOG clinical trial number
SWOG-7314
Evaluation of the Maximum Tolerated Therapeutic Dose of the Combination: Methotrexate and Methyl CCNU
Closed
Abbreviated Title
Evaluation of the Maximum Tolerated Therapeutic Dose of the Combination: Methotrexate and Methyl CCNU
Activated
07/06/1973
Closed
09/01/1974
Publication Information Expand/Collapse
1977
Phase I trial of combination methotrexate and methyl- CCNU in patients with advanced neoplastic diseases.